Outlook Therapeutics, Inc. · NASDAQ:OTLK
GMS Ventures & Investments reported a 16.40% stake in Outlook Therapeutics, Inc. (Schedule 13D/A)
Event Aug 12, 2026 · Filed Aug 14, 2026
GMS Ventures & Investments reported a 16.40% stake in Outlook Therapeutics, Inc., 42,631,142 shares, with active intent on Aug 12, 2026. Filed Aug 14, 2026 (Schedule 13D/A).
- Stake
- 16.40%
- Shares
- 42,631,142
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GMS Ventures & Investments | 16.40% | 42,631,142 |
| SUKHTIAN GHIATH M. | 16.40% | 42,631,142 |
Source
Related
- Outlook Therapeutics, Inc.
- GMS Ventures & Investments
- Outlook Therapeutics, Inc. shareholders
- Schedule 13D/A · GMS Ventures & Investments · Jun 1, 2026
- Schedule 13D/A · GMS Ventures & Investments · May 28, 2025
- Schedule 13D/A · GMS Ventures & Investments · Mar 12, 2025
- Schedule 13D/A · GMS Ventures & Investments · Jan 22, 2025
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026